Nutritional factors and preservation of C-peptide in youth with recently diagnosed type 1 diabetes search nutrition ancillary study

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 1842-1850

  Mayer Davis, Elizabeth J ^a   Dabelea, Dana ^b   Crandell, Jamie L ^c   Crume, Tessa ^b   D'Agostino Jr , Ralph B ^d   Dolan, Lawrence ^e   King, Irena B ^f   Lawrence, Jean M ^g   Norris, Jill M ^b   Pihoker, Catherine ^h   The, Natalie ⁱ  

^a University of North Carolina   (United States)

^b Global Health and Health Disparities   (United States)

^c IL   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^g Children's Hospital and Regional Medical Center ^*  (United States)

^h SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

ⁱ FURMAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AUTOANTIBODY; C PEPTIDE; CARBOHYDRATE; DOCOSAHEXAENOIC ACID; GLUTAMATE DECARBOXYLASE ANTIBODY; ICOSAPENTAENOIC ACID; INSULIN; INSULINOMA ASSOCIATED 2 ANTIBODY; LEUCINE; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG; VITAMIN D;

AGE; BREAST FEEDING; CHILD; CONFERENCE PAPER; CONTINUOUS INFUSION; DEMOGRAPHY; DIET RESTRICTION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE DURATION; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PANCREAS ISLET BETA CELL; PATHOGENESIS; PROGNOSIS; SCHOOL CHILD; WEANING;

ADOLESCENT; AMINO ACIDS, BRANCHED-CHAIN; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FASTING; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84886063865     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2084     Document Type: Conference Paper

References (38)

1. Greenbaum CJ, Anderson AM, Dolan LM, et al.; SEARCH Study Group. Preservation of beta-cell function in autoantibodypositive youth with diabetes. Diabetes Care 2009;32:1839-1844
2. Palmer JP, Fleming GA, Greenbaum CJ, et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004;53:250-264
3. Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial. Diabetes Care 2003;26:832-836
4. Virtanen SM, Knip M. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr 2003;78:1053-1067
5. Yang J, Chi Y, Burkhardt BR, Guan Y, Wolf BA. Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutr Rev 2010;68: 270-279
6. Virtanen SM, Hyppönen E, Läärä E, et al.; Childhood Diabetes in Finland Study Group. Cow'smilk consumption, diseaseassociated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Diabet Med 1998;15:730-738
7. Norris JM, Scott FW. A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? Epidemiology 1996;7:87-92
8. Norris JM, Barriga K, Klingensmith G, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 2003;290:1713-1720
9. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetesassociated autoantibodies. JAMA 2003; 290:1721-1728
10. Stene LC, Joner G; Norwegian Childhood Diabetes Study Group. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, casecontrol study. Am J Clin Nutr 2003;78: 1128-1134
11. Knekt P, Reunanen A, Marniemi J, Leino A, Aromaa A. Low vitamin E status is a potential risk factor for insulin-dependent diabetes mellitus. J Intern Med 1999;245: 99-102
12. Nuttall FQ. Carbohydrate and dietary management of individuals with insulinrequiring diabetes. Diabetes Care 1993;16:1039-1042
13. SEARCH Study Group. SEARCH for Diabetes in Youth: amulticenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004;25:458-471
14. Bonifacio E, Yu L, Williams AK, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia. J Clin Endocrinol Metab 2010;95:3360-3367
15. Erlich H, Valdes AM, Noble J, et al.; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008;57:1084-1092
16. Mayer-Davis EJ, Nichols M, Liese AD, et al.; SEARCH for Diabetes in Youth Study Group. Dietary intake among youth with diabetes: the SEARCH for Diabetes in Youth Study. J Am Diet Assoc 2006;106: 689-697
17. Kostraba JN, Cruickshanks KJ, Lawler- Heavner J, et al. Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes 1993;42:288-295
18. Hollis BW. Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab 2004; 89:3149-3151
19. Cheng TY, Barnett MJ, Kristal AR, et al. Genetic variation in myeloperoxidase modifies the association of serum a-tocopherol with aggressive prostate cancer among current smokers. J Nutr 2011;141:1731-1737
20. Ma J, Folsom AR, Shahar E, Eckfeldt JH; The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middleaged adults. Am J Clin Nutr 1995;62: 564-571
21. King IB, Lemaitre RN, KestinM. Effect of a low-fat diet on fatty acid composition in red cells plasma phospholipids and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr 2006;83:227-236
22. Tacconi M, Wurtman RJ. Rat brain phosphatidyl- N,N-dimethylethanolamine is rich in polyunsaturated fatty acids. Neurochem 1985;45:805-809
23. Lemaitre RN, King IB, Patterson RE, Psaty BM, Kestin M, Heckbert SR. Assessment of trans-fatty acid intake with a food frequency questionnaire and validation with adipose tissue levels of transfatty acids. Am J Epidemiol 1998;148: 1085-1093
24. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-693
25. Dabelea D, Mayer-Davis EJ, Andrews JS, et al. Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 2012;55:3359-3368
26. Vaarala O, Knip M, Paronen J, et al. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 1999;48:1389-1394
27. Hummel S, Pflüger M, Hummel M, Bonifacio E, Ziegler AG. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care 2011;34: 1301-1305
28. Borges MC, Martini LA, Rogero MM. Current perspectives on vitamin D, immune system, and chronic diseases. Nutrition 2011;27:399-404
29. Hyppönen E, Läärä E, Reunanen A, ärvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-1503
30. Simpson M, Brady H, Yin X, et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 2011;54:2779-2788
31. Bizzarri C, Pitocco D, Napoli N, et al; IMDIAB Group. No protective effect of calcitriol on beta-cell function in recentonset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 2010;33:1962-963
32. Walter M, Kaupper T, Adler K, Foersch J,Bonifacio E, Ziegler AG. No effect of the 1alpha,25-dihydroxyvitamin D3 on betacell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 2010;33:1443-1448
33. Sijben JW, Calder PC. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 2007;66:237-259
34. Krishna Mohan I, Das UN. Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition 2001;17: 126-151
35. Virtanen SM, Niinistö S, Nevalainen J, et al. Serumfatty acids and risk of advanced betacell autoimmunity: a nested case-control study among children with HLA-conferred susceptibility to type I diabetes. Eur J Clin Nutr 2010;64:792-799
36. Norris JM, Yin X, LambMM, et al.Omega- 3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 2007;298:1420-1428
37. MillerMR, Yin X, Seifert J, et al. Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes 2011;12:669-675
38. Raz I,EliasD, AvronA,TamirM,MetzgerM, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (Dia-Pep277): a randomised, double-blind, phase II trial. Lancet 2001;358:1749-1753